Heverlee, Belgium

Jan Balzarini

USPTO Granted Patents = 33 


 

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 404(Granted Patents)


Location History:

  • Haverice, BE (2003)
  • Leuven, BE (2006 - 2015)
  • Heverlee, BE (1997 - 2024)

Company Filing History:

goldMedal8 out of 135 
 
University College Cardiff Consultants Limited
 patents
silverMedal7 out of 84 
 
K.u. Leuven Research & Development
 patents
bronzeMedal6 out of 350 
 
Katholieke Universiteit Leuven
 patents
44 out of 4 
 
Rega Foundation
 patents
54 out of 28 
 
Nucana Plc
 patents
64 out of 454 
 
Consejo Superior De Investigaciones Cientificas
 patents
73 out of 5 
 
Nucana Biomed Limited
 patents
82 out of 95 
 
University College Cork
 patents
92 out of 37 
 
Technische Universitat Braunschweig
 patents
101 out of 3,484 
 
Toray Industries, Inc.
 patents
111 out of 259 
 
Medical Research Council
 patents
121 out of 3,566 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
131 out of 5,104 
 
Centre National De La Recherche Scientifique
 patents
141 out of 232 
 
Université´ D'aix-Marseille
 patents
151 out of 239 
 
Katholieke Universiteit Leuven, Ku Leuven R&d
 patents
161 out of 8 
 
Università Degli Studi Di Ferrara
 patents
171 out of 5 
 
Kemin Pharma B.v.b.a.
 patents
184 out of 832,966 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Title: Jan Balzarini - Pioneering Belgian Inventor

Introduction: Jan Balzarini is a distinguished Belgian inventor known for his groundbreaking contributions to the field of pharmaceuticals and antiviral research.

Latest Patents: Jan Balzarini holds several patents related to novel antiviral compounds and pharmaceutical formulations designed to combat a wide range of viral infections.

Career Highlights: With a career spanning over four decades, Jan Balzarini has held prominent positions in various research institutions and pharmaceutical companies, where he has led numerous successful projects resulting in significant advancements in antiviral therapies.

Collaborations: Throughout his career, Jan Balzarini has collaborated with leading scientists, researchers, and pharmaceutical companies worldwide to further the development of innovative antiviral treatments, establishing himself as a key figure in the global fight against viral diseases.

Conclusion: Jan Balzarini's dedication to scientific excellence and his pioneering work in antiviral research have not only earned him international recognition but have also significantly impacted the field of pharmaceuticals, paving the way for the development of new and improved antiviral therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…